|
Market Cap (25-Jun) $125,067,280 (1,258th) |
Close (30-Jun) $0.007 |
Volume (30-Jun) 188,484 |
Shortsold (14-May) 14,985,846 (0.14%) (426th) |
|
52w High $0.85 |
52w Low $0.350 |
P/E 10.33 |
EPS -0.07 |
ATH released this announcement to the ASX on 23 April 2021, 16:53. The announcement is not marked as price sensitive, and is 2 page(s) in length and 81.12kb in size.
You can view all announcements from ATH and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATH was 0.170% short sold according to ASIC data. It was ranked the 396th most shorted stock on the ASX. It remains ranked 426th as of the latest reported data (14 May 2026).
| Other Recent Announcements from ATH | |
|---|---|
| Investor Presentation | 22 June 2023, 11:13 |
| ATH to present at MST Rare Diseases Rich Returns Forum | 21 June 2023, 9:52 |
| ATH starts 2nd Phase 2 Study in Rare Parkinsonian Disorder | 30 May 2023, 13:32 |
| Ceasing to be a substantial holder | 23 April 2021, 16:53 |
| ATH434 protects brain cells and improves motor function | 21 April 2021, 13:07 |
| Appendix 3G | 20 April 2021, 15:48 |
| Change in substantial holding | 15 March 2021, 16:40 |
You must be logged in to post a reply.
Alterity Therapeutics 